Webinar coverage: New treatment marks a turning point in Alzheimer’s care
Health Canada recently approved the first disease-modifying therapy for Alzheimer’s disease, which is a long-awaited milestone that carries significant implications for private drug plans, employers…
- By: Suzanne Lepage
- January 14, 2026 January 13, 2026
- 08:00























